Myriad Genetics (MYGN) Buildings (2015 - 2019)

Myriad Genetics (MYGN) has reported Buildings for 5 consecutive years, with $18.2 million the latest figure, recorded in Q3 2019.

• In Q3 2019, Buildings fell 3.7% year-over-year to $18.2 million; the TTM figure through Sep 2019 stood at $18.2 million (down 3.7% YoY), while the FY2019 annual figure was $18.8 million, down 2.59% from the prior year.
• Buildings eased to $18.2 million in Q3 2019 per MYGN's latest filing, from $18.8 million in the prior quarter.
• Across five years, Buildings topped out at $20.5 million in Q1 2018 and bottomed at $16.1 million in Q4 2016.
• Historically, Buildings has averaged $18.2 million across 5 years, with a median of $18.2 million in 2015.
• Annual changes were most pronounced in 2017 — Buildings fell 13.3% — and 2018, when it gained 25.77%.
• Myriad Genetics' Buildings stood at $17.3 million in 2015, then declined by 6.94% to $16.1 million in 2016, then increased by 22.98% to $19.8 million in 2017, then decreased by 4.55% to $18.9 million in 2018, then declined by 3.7% to $18.2 million in 2019.
• Business Quant data shows MYGN's Buildings at $18.2 million in Q3 2019, $18.8 million in Q2 2019, and $18.6 million in Q1 2019.